Meritain Eldorado policies
Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
11 policies name C9257, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| Cerebral Perfusion Studies | 0663 · Commercial | 9 | Original policy ↗ |
| 1021-Mirvetuximab Soravtansine-gynx (Elahere) | 1021 · Commercial | 10 | Original policy ↗ |
| Optic Nerve and Retinal Imaging Methods | 0344 · Commercial | 15 | Original policy ↗ |
| Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | 0701 · Commercial | 29 | Original policy ↗ |
| 0795-Dexamethasone Ophthalmic Implant (Ozurdex) and Insert (Dextenza) | 0795 · Commercial | 31 | Original policy ↗ |
| 0765-Age-related Macular Degeneration | 0765 · Commercial | 47 | Original policy ↗ |
| Hypertrophic Scars and Keloids | 0389 · Commercial | 56 | Original policy ↗ |
| 0892-Nivolumab Products (Opdivo, Opdivo Qvantig, and Opdualag) | 0892 · Commercial | 58 | Original policy ↗ |
| 0111-Indocyanine Green Angiography | 0111 · Commercial | 60 | Original policy ↗ |
| Glaucoma Surgery | 0484 · Commercial | 65 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |